Business
TAO Synergies Announces $11 Million Private Placement
Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG NEW YORK, Oct. 13, 2025 /PRNewswire/ -- TAO Synergies
About this update from Tao Synergies Inc.
[{"type":"text","content":"\n \n Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG\n \n \n \n NEW YORK, Oct. 13, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the \"Company\"), a digital asset treasury company focused on Bittensor (TAO), the premier cryptotoken for decentralized artificial intelligence (DeAI), today announced that it has entered into a securities purchase agreement with existing investors, James Altucher and a new investor, DCG, for a $11 million financing.\n \"TAO Synergies' latest financing further supports its continuing strategic investments not only in TAO tokens, but also in potential opportunities to earn revenue and accrue additional TAO within the Bittensor ecosystem,\" said James Altucher. \"We are pleased to welcome our new strategic investor DCG, a leader in the cryptocurrency and blockchain industry and a major investor and incubator in the Bittensor ecosystem. We have strong conviction in Bittensor's vision for decentralized intelligence and believe its network model will be a key driver of innovation and value creation in the years ahead.\"\n The financing involves the sale of 11,000 shares of the Company's newly issued Series E convertible preferred stock (\"preferred stock\"), with a stated value of $1,000 per share which is convertible into shares of the Company's common stock, and associated five-year common stock purchase warrants, in a private placement priced above the five-day trailing average price. The shares of Series E preferred stock have a conversion price of $8.00 per share. The warrants have an exercise price of $8.00 per common share.\n The transaction is expected to close on or about October 15, 2025, subject to the satisfaction of customary closing conditions.\n The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the \"Act\") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant ...